Cambridge Investment Research Advisors’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8
| Closed | -$39K | – | 3165 |
|
|
2021
Q4 | $39K | Buy |
8
+4
| +100% | +$19.5K | ﹤0.01% | 3111 |
|
|
2021
Q3 | $27K | Hold |
4
| – | – | ﹤0.01% | 3046 |
|
|
2021
Q2 | $34K | Buy |
+4
| New | +$34K | ﹤0.01% | 3045 |
|
|
2020
Q2 | – | Sell |
-7
| Closed | -$48K | – | 2457 |
|
|
2020
Q1 | $48K | Buy |
7
+1
| +17% | +$6.86K | ﹤0.01% | 2183 |
|
|
2019
Q4 | $99K | Hold |
6
| – | – | ﹤0.01% | 2313 |
|
|
2019
Q3 | $61K | Sell |
6
-1
| -14% | -$10.2K | ﹤0.01% | 2264 |
|
|
2019
Q2 | $104K | Buy |
7
+1
| +17% | +$14.9K | ﹤0.01% | 2097 |
|
|
2019
Q1 | $99K | Sell |
6
-1
| -14% | -$16.5K | ﹤0.01% | 2190 |
|
|
2018
Q4 | $61K | Sell |
7
-6
| -46% | -$52.3K | ﹤0.01% | 2076 |
|
|
2018
Q3 | $169K | Buy |
+13
| New | +$169K | ﹤0.01% | 2085 |
|